Abstract
The original grant information has been corrected to the following: This work was supported by award number 1R43GM122196-01 (Centralized Assay Data Sets for Modeling Support of Small Drug Discovery Organizations) from NIH/NIGMS. Some of the data sets were previously built partially with funding from aware number 9R44TR000942-02 Biocomputation Across Distributed Private Data Sets to Enhance Drug Discovery from the NIH National Center for Advancing Translational Sciences. J.S.F. and S.E. were supported by funding from NIH/NIAID (1U19AI109713) for the Center to Develop Therapeutic Countermeasures to High-Threat Bacterial Agents, from the NIH: Centers of Excellence for Translational Research (CETR). J.S.F. acknowledges funding from NIH/NIAID (2R42AI088893-02) and Rutgers University, NJMS. T.L. was partially supported by funds from the Office of Graduate Education at the University of North Carolina to support its internship program.
| Original language | English |
|---|---|
| Pages (from-to) | 2833 |
| Number of pages | 1 |
| Journal | Molecular Pharmaceutics |
| Volume | 18 |
| Issue number | 7 |
| DOIs |
|
| State | Published - 5 Jul 2021 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver